Summary:
In adults with type 2 diabetes, various glucose-lowering medications as studied in the GRADE trial
showed small differences in medication adherence and unclear clinical impact on glycemic control
compared to other treatment groups within the comparative effectiveness study, though lower adherence was strongly associated with worsening glycemic control.
| PICO | Description |
|---|---|
| Population | Adults with type 2 diabetes enrolled in the GRADE study, receiving glucose-lowering therapies. |
| Intervention | Four distinct glucose-lowering treatments as part of the GRADE comparative effectiveness trial. |
| Comparison | Other glucose-lowering treatments evaluated within the GRADE study arms. |
| Outcome | Adherence was generally high across treatment groups with minimal differences; however, lower adherence strongly predicted deterioration in glycemic control, underscoring the need for regular adherence assessment. |
Source: Gonzalez, Jeffrey S, et al. “Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).” Read article here.